Skip to main content
Premium Trial:

Request an Annual Quote

Revenues Jump, Losses Shrink for Gene Logic in Q2

NEW YORK, July 29-Gene Logic today reported a steep hike in revenue and halved net losses for the first quarter of 2002.


For the reporting period ending June 30, 2002, company losses were $4.4 million, or $0.16 per share, down from $9.4 million or $0.35 per share in the equivalent period in 2001.


At the end of the quarter, company revenues were $14.1 million, an increase of 46 percent over the $9.6 million reported in the second quarter of the previous year.


Revenues were boosted by subscriptions to the company's GeneExpress database, including a new agreement with Shering-Plough.


However, Gene Logic also warned that it expected revenue growth to slow during the rest of the year, due to a slowdown in new customers.


The company said that it held cash and cash equivalents worth $180 million as of June 30, 2002.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.